The raise was led by Atlas Venture, Forbion and a new backer in the form of Schroders. Other new investors who participated in the round include Amgen Ventures, Athos Capital, CDP Venture Capital, Columbia IMC, Neva SGR, Sixty Degree Capital, XGen Venture and Willett Advisors.
